Tariff amendment reclassifies ceftazidime as a drug intermediate and reduces its customs duty under amended notifications. Central government amends three customs exemption notifications by omitting a specified table entry in one, inserting tariff designation 7 ACA in another, and adding ceftazidime as a listed entry in a third, thereby altering the tariff classification and treatment of that drug intermediate.